Virinchi Limited announced the allotment of 86,00,000 (Eighty-Six Lakh) convertible equity warrants to Vivo Bio Tech Limited, a promoter group entity. The allotment was approved by the Stakeholders Relationship Committee at a meeting held on Thursday, January 08, 2026. These warrants were issued on a preferential basis at an issue price of ₹28 per warrant, consisting of a face value of ₹10 and a premium of ₹18. The company received 25% of the issue price, amounting to ₹7 per warrant, upon allotment.

The issuance of these warrants follows a special resolution passed by shareholders at an Extra-Ordinary General Meeting on Saturday, November 15, 2025, and received in-principle approval from BSE and NSE on December 31, 2025. The remaining 75% of the issue price (₹21 per warrant) is to be received for the conversion of each warrant into one fully paid-up equity share. The warrants have a tenure of 18 months from the date of allotment for conversion.

Post this allotment, the total share capital of the company remains unchanged. However, assuming the conversion of these warrants, the shareholding pattern indicates an increase in the Promoter and Promoter Group's stake from 37.51% to 42.34%, while the Public shareholding would decrease from 62.49% to 57.66%. The total number of shares post-issue is expected to be 11,12,46,896.